文献速递乳腺癌放疗胸部肿瘤放疗

冠脉钙化与放疗对高危乳腺癌患者冠心病风险的影响:DBCG RT-Nation队列

The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort.
PubMed 文献 · Radiother Oncol · 2024-12-25

该队列纳入丹麦西部2008—2016年3355例高危乳腺癌放疗患者,分析计划CT的Agatston评分(AS)与心脏剂量参数对冠心病(CAD)风险的影响。AS≥100者CAD风险显著高于AS<100者(HR 9.51,95%CI 5.16—17.53),十年绝对累积风险差6.7%(7.7% vs 1%)。AS<100者CAD风险随平均心脏剂量(MHD)升高(每Gy HR 1.25,95%CI 1.01—1.56);AS≥100者风险主要由钙化驱动而非剂量。

要点

  • AS≥100 vs AS<100的CAD风险HR 9.51(95%CI 5.16—17.53)。
  • AS<100者每Gy MHD的CAD风险HR 1.25(95%CI 1.01—1.56)。
  • AS≥100者CAD风险由钙化驱动而非放疗剂量。

核心结论

  • 计划CT测得的AS可预测接受放疗的乳腺癌患者的CAD风险和总生存。
  • 低钙化患者中MHD仍是最强预测因子,高钙化患者中基线钙化风险强于剂量相关风险。

研究设计与样本

  • 队列研究纳入丹麦西部2008—2016年3355例高危乳腺癌放疗患者,分析CT扫描、治疗计划与剂量分布,以Agatston评分(AS)测量冠脉钙化。
  • 分析MHD、LV5及LAD_mean与CAD的剂量-反应关系及放疗时CAC存在的影响,次要分析评估总生存。

主要发现

  • 3355例中45例(1.2%)随访期间发生CAD。
  • AS≥100 vs AS<100的CAD风险HR 9.51(95%CI 5.16—17.53),十年绝对累积CAD风险差6.7%(7.7% vs 1%)。
  • AS<100者(占97%)CAD风险随MHD升高,每Gy HR 1.25(95%CI 1.01—1.56)。
  • AS≥100者CAD风险由CAC驱动而非放疗剂量,CAC与较差总生存相关。
  • 全队列中位MHD为1.25 Gy(IQR 1.01—1.56)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiotherapy improves outcomes for breast cancer. However, prior studies have correlated the risk of coronary artery disease (CAD) to the mean heart dose (MHD), mean dose to the left anterior descending artery (LAD_mean) and the left ventricle V5Gy (LV5). Other studies showed an increased risk of CAD for patients with pronounced coronary artery calcification (CAC) at the time of radiotherapy. MATERIALS AND METHODS: This cohort study included 3355 high-risk breast cancer patients treated in Western Denmark (2008-2016). We analysed CT scans, treatment plans, and dose distributions. CAC was measured using the Agatston score (AS). We examined the dose-response relationship between MHD, LV5 and LAD_mean and CAD, and the effect of CAC presence at radiotherapy. Secondary analysis assessed overall survival. RESULTS: Of 3355 patients, 45 (1.2 %) developed CAD during follow-up. AS was a strong predictor of CAD risk with a hazard ratio of 9.51(CI95:5.16-17.53) for AS ≥ 100 versus AS < 100 and a 6.7 % difference in absolute cumulative CAD risk at ten years (7.7 % vs 1 %). For AS < 100 (97 % of patients) CAD risk increased with MHD, hazard ratio 1.25 (CI95:1.01-1.56) per Gy. ForAS ≥ 100, CAD risk was driven by CAC rather than radiation dose. CAC was associated with poorer overall survival. Median MHD for the whole cohort was 1.25 Gy (IQR:1.01-1.56). CONCLUSION: AS from planning CT-scans predicted CAD risk and overall survival in breast cancer patients receiving radiotherapy. The MHD remained the strongest predictor in patients with low CAC. For patients with high CAC, the high baseline risk from CAC was a stronger risk factor than the dose-related risk.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Refsgaard L, Holm Milo ML, Buhl ES, et al. The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort. Radiother Oncol. 2024. PMID: 39725067. doi:10.1016/j.radonc.2024.110705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。